J. Sabatino

发表

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis

J. Derisi, S. Baranzini, S. Hauser, 2020, Proceedings of the National Academy of Sciences.

Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis

V. Secor, Melissa A Brown, J. Sabatino, 2005, European journal of immunology.

Low 2-Dimensional CD4 T Cell Receptor Affinity for Myelin Sets in Motion Delayed Response Kinetics

B. Evavold, Cheng Zhu, J. Sabatino, 2012, PloS one.

T cells take aim at a ubiquitous autoantigen in multiple sclerosis

S. Zamvil, J. Sabatino, 2018, Science Translational Medicine.

Loss of IFN-γ Enables the Expansion of Autoreactive CD4+ T Cells to Induce Experimental Autoimmune Encephalomyelitis by a Nonencephalitogenic Myelin Variant Antigen1

J. Altman, B. Evavold, M. Ford, 2008, Journal of Immunology.

Unique invariant CD8+ T cell population persists in MS

S. Zamvil, J. Sabatino, 2015, Neurology: Neuroimmunology & Neuroinflammation.

Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice.

M. Eichner, T. Biedermann, W. Weber, 2007, Arthritis and rheumatism.

SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron

J. Derisi, D. Havlir, M. Laurie, 2022, The Journal of infectious diseases.

SARS-CoV-2 variant exposures elicit antibody responses with differential cross-neutralization of established and emerging strains including Delta and Omicron

J. Derisi, D. Havlir, M. Laurie, 2021, medRxiv : the preprint server for health sciences.

A common allele of HLA mediates asymptomatic SARS-CoV-2 infection

J. Olgin, M. Pletcher, G. Marcus, 2022, medRxiv.

Acute liver injury in a Glatopa-treated patient with MS

S. Kakar, S. Zamvil, B. Cree, 2017, Neurology: Neuroimmunology & Neuroinflammation.

B-Cell Therapies in Multiple Sclerosis.

S. Hauser, S. Zamvil, J. Sabatino, 2019, Cold Spring Harbor perspectives in medicine.

Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis

P. Calabresi, S. Hauser, S. Zamvil, 2019, Proceedings of the National Academy of Sciences.

Self-reactive human CD4 T cell clones form unusual immunological synapses

Susana Gordo, Michael Loran Dustin, K. Wucherpfennig, 2012, The Journal of experimental medicine.

Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity

S. Zamvil, M. Wilson, R. Bove, 2021, medRxiv.

B cells in autoimmune and neurodegenerative central nervous system diseases

S. Zamvil, A. Pröbstel, J. Sabatino, 2019, Nature Reviews Neuroscience.

NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease

L. Lawrence, B. Evavold, J. Sabatino, 2017, The Journal of Immunology.

This information is current as Demyelinating Disease High-Affinity T Cells Necessary for Onset of Expand a Critical Threshold Level of NFM Cross-Reactivity to MOG Does Not

L. Lawrence, B. Evavold, J. Sabatino, 2017 .

High prevalence of low affinity peptide–MHC II tetramer–negative effectors during polyclonal CD4+ T cell responses

B. Evavold, Jun Huang, J. Sabatino, 2011, The Journal of experimental medicine.

Manipulating Antigenic Ligand Strength to Selectively Target Myelin-Reactive CD4+ T Cells in EAE

B. Evavold, J. Sabatino, Kristen M. Rosenthal, 2010, Journal of Neuroimmune Pharmacology.

Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients

S. Zamvil, R. Bove, D. Holm, 2022, Multiple Sclerosis and Related Disorders.

Persistently reduced humoral and cellular immune response following third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients

S. Zamvil, R. Bove, D. Holm, 2022, medRxiv.

Humoral immune response following SARS-CoV-2 mRNA vaccination concomitant to anti-CD20 therapy in multiple sclerosis

S. Zamvil, M. Wilson, R. Bove, 2021, Multiple Sclerosis and Related Disorders.

Remote Observational Research for Multiple Sclerosis

D. Goodin, S. Hauser, R. Lincoln, 2022, Neurology: Neuroimmunology & Neuroinflammation.

Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators

S. Zamvil, M. Wilson, R. Bove, 2022, Multiple Sclerosis and Related Disorders.

A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection

J. Olgin, M. Pletcher, G. Marcus, 2023, Nature.

T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity

Mark S. Anderson, J. Sidney, A. Sette, 2023, Proceedings of the National Academy of Sciences of the United States of America.

Aryl hydrocarbon receptor activity may serve as a surrogate marker for MS disease activity

S. Zamvil, J. Sabatino, 2017, Neurology: Neuroimmunology & Neuroinflammation.

A distinct cross-reactive autoimmune response in multisystem inflammatory syndrome in children (MIS-C)

12, J. Derisi, N. Cvijanovich, 2023, medRxiv.

A distinct cross-reactive autoimmune response in multisystem inflammatory syndrome in children (MIS-C)

12, J. Derisi, N. Cvijanovich, 2023, medRxiv.

A rare case of hyponatremia from a hypothalamic lesion in a patient with multiple sclerosis

S. Newsome, J. Sabatino, J. Werner, 2015, Multiple sclerosis.